Strados Labs

📍 Philadelphia, United States🗓 Founded 2016👥 46 employees💰 Last funded Dec 2025
Biotechnology Research🌐 stradoslabs.com
Website LinkedIn
Strados Labs is a clinical research technology company transforming how respiratory disease is measured and understood. Our proprietary RESP® Biosensor is the first FDA 510(k) cleared and CE marked wearable system that continuously captures lung sounds, including cough and wheeze, across clinical and real-world environments. By passively collecting high-fidelity lung acoustics and physiological signals, RESP enables objective, continuous respiratory measurement for clinical trials and care. Physician and asthma patient-founded, Strados partners with pharmaceutical, biotechnology, and research organizations to generate novel respiratory endpoints, improve therapeutic insight, and advance outcomes for patients with pulmonary disease.
3
Total investors
1
Early stage
0
Mid stage
2
Late stage
2016
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Hong Kong SAR
1
Investor activity2017–2025 · investors recorded per year
201712024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Strados Labs?
Strados Labs has 3 investors on record on gritt.io, including 1 early-stage backers and 2 late-stage investors.
When did Strados Labs last raise funding?
The most recent investment in Strados Labs recorded on gritt.io was in December 2025.
When was Strados Labs founded?
Strados Labs was founded in 2016.
What industry is Strados Labs in?
Strados Labs operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Strados Labs based?
Strados Labs is headquartered in Philadelphia, United States.